Three clinically significant and highly studied genes were selected as target genes for each cancer type: HERE2, MYBL2, and MMP11 for BRCA (Paik et al., 2004) and NOTCH2, BRCA1, and PDC for COAD (Abdul Aziz et al., 2016). This evidence concerns the gene PDC and cancer.